{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:16:11Z","timestamp":1792077371289,"version":"4.4.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>COVID-19 vaccine\u2013derived antibodies in pregnant people may protect infants from severe infection in the first 6 months of life via transplacental antibody transfer. Few data exist on maternally derived SARS-CoV-2 antibodies in preterm compared with full-term infants in association with vaccination timing.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare SARS-CoV-2 anti-Spike (anti-S) antibody levels in preterm and full-term infants in the context of vaccine dose timing before delivery.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This prospective cohort study enrolled pregnant individuals and collected paired maternal and cord blood samples at delivery at the University of Washington between February 1, 2021, and January 31, 2023. Participants who had received at least 2 doses of a messenger RNA COVID-19 vaccine before delivery and did not have a history of prior COVID-19 infection or detectable anti\u2013SARS-CoV-2 nucleocapsid antibodies were included.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Timing of the last vaccine dose and preterm or full-term gestational age at delivery.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Paired maternal and cord samples were tested for anti-S antibody, and linear regression was used to evaluate associations between preterm delivery and anti-S antibody levels. Covariates included timing of last dose, number of doses, insurance status, and immunosuppressing medications.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 220 participants (median [IQR] age, 34 [32-37] years; 212 [96.4%] female) with 36 preterm and 184 full-term deliveries were studied. Before delivery, 121 persons received 2 vaccine doses and 99 persons received 3 or more vaccine doses. The geometric mean concentration of maternal anti-S antibodies was 674 (95% CI, 577-787) after 2 doses and 8159 (95% CI, 6636-10\u202f032) after 3 or more doses (P<\/jats:italic>\u2009&amp;lt;\u2009.001). The cord anti-S antibody geometric mean concentration was 1000 (95% CI, 874-1144) after 2 doses and 9992 (95% CI, 8381-11\u202f914) after 3 or more doses (P<\/jats:italic>\u2009&amp;lt;\u2009.001). After adjustment for vaccine timing and number of doses before delivery, no association was found between preterm delivery and cord anti-S antibody levels (\u03b2\u2009=\u20090.44; 95% CI, \u22120.06 to 0.94).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this prospective cohort study of pregnant individuals with preterm and full-term deliveries, receipt of 3 or more compared with 2 doses of COVID-19 vaccine before delivery resulted in 10-fold higher cord anti-S antibody levels. Maternal antibody concentration appeared more important than delivery gestational age in determining cord anti-S antibody levels. The number of doses and timing considerations for COVID-19 vaccine in pregnancy should include individuals at risk for preterm delivery.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.52387","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T16:31:14Z","timestamp":1705681874000},"page":"e2352387","source":"Crossref","is-referenced-by-count":16,"title":["Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born Preterm"],"prefix":"10.1001","volume":"7","author":[{"given":"Alisa","family":"Kachikis","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Pike","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda O.","family":"Eckert","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington, Seattle"},{"name":"Department of Global Health, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Frank","sequence":"additional","affiliation":[{"name":"School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Goecker","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Gravett","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Washington, Seattle"},{"name":"Department of Global Health, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Greninger","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital Research Institute, Department of Pediatrics, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"issue":"3","key":"zoi231534r1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41591-021-01666-2","article-title":"SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland.","volume":"28","author":"Stock","year":"2022","journal-title":"Nat Med"},{"issue":"8","key":"zoi231534r2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jama.2021.11035","article-title":"Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women.","volume":"326","author":"Goldshtein","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"zoi231534r3","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","article-title":"Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.","volume":"27","author":"Dagan","year":"2021","journal-title":"Nat Med"},{"issue":"38","key":"zoi231534r4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.15585\/mmwr.mm6938e1","article-title":"Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19\u2014COVID-NET, 13 states, March 1-August 22, 2020.","volume":"69","author":"Delahoy","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"zoi231534r5","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22-October 3, 2020.","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10375","key":"zoi231534r6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(22)02467-9","article-title":"Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.","volume":"401","author":"Villar","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"zoi231534r7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/AOG.0000000000004693","article-title":"Association of gestational age at coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a vaccine booster dose with maternal and umbilical cord antibody levels at delivery.","volume":"139","author":"Yang","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"7","key":"zoi231534r8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","article-title":"Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months\u201417 states, July 2021-January 2022.","volume":"71","author":"Halasa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"zoi231534r10","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1542\/peds.2009-0913","article-title":"New intrauterine growth curves based on United States data.","volume":"125","author":"Olsen","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"zoi231534r11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/03014460.2020.1817555","article-title":"Differential classification of infants in United States neonatal intensive care units for weight, length, and head circumference by United States and international growth curves.","volume":"47","author":"Ferguson","year":"2020","journal-title":"Ann Hum Biol"},{"issue":"6","key":"zoi231534r13","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222.","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi231534r16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/aji.1996.36.issue-5","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy.","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"zoi231534r18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/AOG.0000000000004867","article-title":"Maternal and neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G levels after the Pfizer-BioNTech booster dose for coronavirus disease 2019 (COVID-19) vaccination during the second trimester of pregnancy.","volume":"140","author":"Kugelman","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"7","key":"zoi231534r19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/jama.2022.0470","article-title":"Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants.","volume":"327","author":"Accorsi","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"zoi231534r20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41467-023-36547-4","article-title":"Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life.","volume":"14","author":"Zerbo","year":"2023","journal-title":"Nat Commun"},{"issue":"5040","key":"zoi231534r21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/2101070a0","article-title":"Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport.","volume":"210","author":"Kohler","year":"1966","journal-title":"Nature"},{"key":"zoi231534r22","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.jinf.2016.04.027","article-title":"Maternal immunization: optimizing protection for the mother and infant.","volume":"72","author":"Kachikis","year":"2016","journal-title":"J Infect"},{"issue":"2","key":"zoi231534r23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.earlhumdev.2010.11.003","article-title":"Transplacental transport of IgG antibodies to preterm infants: a review of the literature.","volume":"87","author":"van den Berg","year":"2011","journal-title":"Early Hum Dev"},{"issue":"2","key":"zoi231534r24","first-page":"59","article-title":"Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population.","volume":"19","author":"Okoko","year":"2001","journal-title":"J Health Popul Nutr"},{"issue":"4","key":"zoi231534r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094714","article-title":"Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.","volume":"9","author":"van den Berg","year":"2014","journal-title":"PLoS One"},{"key":"zoi231534r26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijid.2023.02.022","article-title":"Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.","volume":"130","author":"Zilver","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"1","key":"zoi231534r27","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/s41467-022-31169-8","article-title":"Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms.","volume":"13","author":"Atyeo","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"zoi231534r28","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1038\/s41467-022-32188-1","article-title":"Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy.","volume":"13","author":"Prahl","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"zoi231534r29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cmi.2021.10.003","article-title":"Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study.","volume":"28","author":"Rottenstreich","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"zoi231534r15"},{"key":"zoi231534r17","volume-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021"},{"key":"zoi231534r9","unstructured":"Equator Network. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies: Equator Network; 2021. Updated September 10, 2021. Accessed December 6, 2023. https:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/"},{"key":"zoi231534r12","unstructured":"Centers for Disease Control and Prevention. National Health Interview Survey: glossary. Accessed December 6, 2023. https:\/\/www.cdc.gov\/nchs\/nhis\/rhoi\/rhoi_glossary.htm"},{"key":"zoi231534r14","unstructured":"Roche Diagnostics GmbH. Elecsys\u00ae Anti-SARS-CoV-2. Accessed December 6, 2023. https:\/\/diagnostics.roche.com\/us\/en\/products\/params\/elecsys-anti-sars-cov-2.html"},{"key":"zoi231534r30","unstructured":"Roche Diagnostics GmbH. Elecsys Anti-SARS-CoV-2 S: instructions for use. September 25, 2023. Accessed December 6, 2023. https:\/\/www.fda.gov\/media\/144037\/download"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2814091\/kachikis_2024_oi_231534_1704921074.35633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T16:31:21Z","timestamp":1705681881000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2814091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.52387","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]}}}